🔎 Trials Near Me

Akèy › Maladi Greff-versus-host › Illinois › Chicago

Etid klinik pou Maladi Greff-versus-host nan Chicago, IL

3 etid pou Maladi Greff-versus-host ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

Ap rekriteFaz 2
  • The University of Chicago Medical Center (UCMC), Chicago
Laj 2 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT04710576

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Ap rekriteFaz 2
  • University of Chicago, Chicago
Laj 2 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT04380740

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Ap rekriteFaz 2
  • University of Illinois Medical Center - Hematology & Oncology, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561

Etid Maladi Greff-versus-host nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.